Stephen Bagley
University of Pennsylvania
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stephen Bagley as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:09 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07209241 · Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBMUniversity of Pennsylvania · active not recruiting · Recurrent Glioblastoma · principal investigator
- Ph1NCT06973096 · CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial RadiotherapyUniversity of Pennsylvania · active not recruiting · Glioblastoma · principal investigator
- Ph2NCT05345002 · All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant GliomaStephen Bagley, MD, MSCE · recruiting · Glioma, IDH Mutation, Astrocytoma · principal investigator
- Ph1NCT05168423 · CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBMUniversity of Pennsylvania · active not recruiting · Glioblastoma · principal investigator
- Ph2NCT04225039 · Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent GlioblastomaUniversity of Pennsylvania · active not recruiting · Glioblastoma · principal investigator
- Ph2NCT03969706 · Abemaciclib in Patients With OligodendrogliomaStephen Bagley, MD, MSCE · completed · Oligodendroglioma, Adult · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:09 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.Nat Med · 2024364 citationsRCR 43.7
- Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.Nat Cancer · 2024175 citationsRCR 20.1
- Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.Nat Med · 2025106 citationsRCR 22.3
- Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy.Cell Stem Cell · 202595 citationsRCR 20.9
- Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma.Clin Cancer Res · 202512 citationsRCR 2.5
- A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma.Neuro Oncol · 202512 citationsRCR 2.1
- 10 citationsRCR 0.5